PHARMACODYNAMICS OF CYTOSINE-ARABINOSIDE (ARA2C) IN PATIENTS WITH ACUTE MYELOID-LEUKEMIA AND RESULTS OF THERAPY

被引：0
|
作者：
VANPROOIJEN, HC [1 ]
VANDERKLEYN, E [1 ]
HAANEN, C [1 ]
机构：
[1] CATHOLIC UNIV NIJMEGEN,DEPT INTERNAL MED,DIV HAEMATOL,NIJMEGEN,NETHERLANDS
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 1977年 / 35卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：673 / 674
页数：2
相关论文
共 50 条
  • [21] THE COST-EFFECTIVENESS OF IDARUBICIN CYTOSINE-ARABINOSIDE VERSUS DAUNORUBICIN CYTOSINE-ARABINOSIDE IN THE TREATMENT OF ADULTS WITH ACUTE MYELOID-LEUKEMIA
    PASHKO, S
    JACOBS, J
    SANTORSA, J
    CLINICAL THERAPEUTICS, 1991, 13 (03) : 353 - 360
  • [22] ETOPOSIDE (VP-16) AND CYTOSINE-ARABINOSIDE (ARA-C) COMBINATION FOR SECONDARY AND RELAPSED ACUTE MYELOID-LEUKEMIA (AML)
    LAZZARINO, M
    MORRA, E
    INVERARDI, D
    ALESSANDRINO, EP
    BERNASCONI, P
    MERANTE, S
    BERNASCONI, C
    LEUKEMIA RESEARCH, 1986, 10 (01) : 111 - 111
  • [23] THERAPY OF REFRACTORY RELAPSED ACUTE MYELOID-LEUKEMIA AND BLAST CRISIS OF CHRONIC MYELOID-LEUKEMIA WITH THE COMBINATION OF CYTOSINE-ARABINOSIDE, TETRAHYDROURIDINE, AND CARBOPLATIN
    MARSH, JH
    KREIS, W
    BARILE, B
    AKERMAN, S
    SCHULMAN, P
    ALLEN, SL
    DEMARCO, LC
    SCHUSTER, MW
    BUDMAN, DR
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1993, 31 (06) : 481 - 484
  • [24] TREATMENT OF ACUTE MYELOID-LEUKEMIA WITH INTERMEDIATE-DOSE CYTOSINE-ARABINOSIDE AND MITOXANTRONE
    BRITOBABAPULLE, F
    CATOVSKY, D
    NEWLAND, AC
    GOLDMAN, JM
    GALTON, DAG
    SEMINARS IN ONCOLOGY, 1987, 14 (02) : 51 - 52
  • [25] LOW-DOSE CYTOSINE-ARABINOSIDE IN PATIENTS WITH ACUTE MYELOID-LEUKEMIA NOT ELIGIBLE FOR STANDARD CHEMOTHERAPY
    PASCARELLA, A
    MARRANI, C
    LEONI, F
    CIOLLI, S
    NOZZOLI, C
    CAPORALE, R
    SALTI, F
    FERRINI, PR
    LEUKEMIA & LYMPHOMA, 1995, 18 (5-6) : 465 - 469
  • [26] SALIVARY-GLANDS ENLARGEMENT IN ASSOCIATION WITH CYTOSINE-ARABINOSIDE APPLICATION IN PATIENTS WITH ACUTE MYELOID-LEUKEMIA
    CETKOVSKY, P
    KOZA, V
    EUROPEAN JOURNAL OF CANCER, 1994, 30A (11) : 1727 - 1728
  • [27] INDUCTION OF DIFFERENTIATION IN HUMAN MYELOID-LEUKEMIA CELLS WITH CYTOSINE-ARABINOSIDE
    BERAN, M
    HITTELMAN, WN
    ANDERSSON, BS
    MCCREDIE, KB
    LEUKEMIA RESEARCH, 1986, 10 (08) : 1033 - &
  • [28] THERAPY OF SECONDARY ACUTE MYELOID-LEUKEMIA (SEK-AML) WITH HIGH-DOSED (HD-ARA-C) AND MEDIUM-DOSED (ID-ARA-C) CYTOSINE-ARABINOSIDE
    LEITHA, T
    WIENER KLINISCHE WOCHENSCHRIFT, 1986, 98 (17) : 589 - 589
  • [29] LOW-DOSE CYTOSINE-ARABINOSIDE FOR TREATMENT OF ACUTE MYELOID-LEUKEMIA - 3 CASES
    ANDREY, C
    BERIS, P
    PLANCHEREL, C
    DELOES, S
    MAURICE, P
    CHAPUIS, B
    SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT, 1983, 113 (27-2) : 980 - 984
  • [30] STRUCTURAL-ANALYSIS OF THE DEOXYCYTIDINE KINASE GENE IN PATIENTS WITH ACUTE MYELOID-LEUKEMIA AND RESISTANCE TO CYTOSINE-ARABINOSIDE
    FLASSHOVE, M
    STRUMBERG, D
    AYSCUE, L
    MITCHELL, BS
    TIRIER, C
    HEIT, W
    SEEBER, S
    SCHUTTE, J
    LEUKEMIA, 1994, 8 (05) : 780 - 785
12345